Cargando…

Letter in response to: “Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose—the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial”

Detalles Bibliográficos
Autores principales:	Karlsson, Jan Olof G., Jynge, Per, Lundström, Ingemar, Ignarro, Louis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591909/ https://www.ncbi.nlm.nih.gov/pubmed/31234946 http://dx.doi.org/10.1186/s13063-019-3476-3

Ejemplares similares

Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial
por: Dear, James
Publicado: (2019)

Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial)
por: Morrison, Emma E., et al.
Publicado: (2019)

Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol Overdose
por: Pettie, Janice M., et al.
Publicado: (2019)

Impact of Amending the Acetylcysteine Marketing Authorisation on Treatment of Paracetamol Overdose
por: Thompson, G., et al.
Publicado: (2013)

Efficacy of a two bag acetylcysteine regimen to treat paracetamol overdose (2NAC study)
por: Wong, Anselm, et al.
Publicado: (2020)

Delayed presentation of paracetamol overdose
por: Els, Johnre Retief, et al.
Publicado: (2020)

Paracetamol overdose: Acute liver failure and acute kidney injury following an overdose of paracetamol: case report
Publicado: (2020)

Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir?
por: Karlsson, Jan Olof G.
Publicado: (2019)

Survival after an overdose of Distalgesic (dextropropoxyphene and paracetamol).
por: Ruane, B. J., et al.
Publicado: (1989)

Systems Toxicology Approach to Identifying Paracetamol Overdose
por: Mason, Chantelle L., et al.
Publicado: (2018)

Paracetamol overdose: Various toxicities: case report
Publicado: (2021)

Accidental staggered paracetamol overdose: An interesting case report
por: Aabideen, Kanakkande, et al.
Publicado: (2011)

Gastric tonometry in patients recovering from paracetamol overdose
por: Rhodes, A, et al.
Publicado: (1998)

Risk Factors for Hepatotoxicity Due to Paracetamol Overdose in Adults
por: Popiolek, Iwona, et al.
Publicado: (2021)

Fomepizole should not be used more liberally in paracetamol overdose
por: Dear, James W.
Publicado: (2022)

Paracetamol overdose: Drug-induced liver injury: case report
Publicado: (2022)

Co-administration of fresh grape fruit juice (GFJ) and bergamottin prevented paracetamol induced hepatotoxicity after paracetamol overdose in rats
por: Baleni, Refuoe, et al.
Publicado: (2015)

Suspected paracetamol overdose in Monrovia, Liberia: a matched case–control study
por: Haidar, Mohamad K., et al.
Publicado: (2020)

Acute Renal Impairment in Patients Due to Paracetamol Overdose in the Absence of Hepatic Impairment
por: Khan, Zahid, et al.
Publicado: (2021)

Correction to: Suspected paracetamol overdose in Monrovia, Liberia: a matched case–control Study
por: Haidar, Mohamad K., et al.
Publicado: (2020)

Implementation and outcome of an electronic tool for detection of paracetamol overdose in a tertiary care hospital
por: Cabrera-Diaz, Francisco, et al.
Publicado: (2020)

Evaluation of cut-off values in acute paracetamol overdose following the United Kingdom guidelines
por: Jeong, Hyun Ho, et al.
Publicado: (2022)

Low rates of hepatotoxicity among Asian patients with paracetamol overdose: a review of 1024 cases
por: Marzilawati, Abd-Rahman, et al.
Publicado: (2012)

A review of the evidence concerning hepatic glutathione depletion and susceptibility to hepatotoxicity after paracetamol overdose
por: Kalsi, Sarbjeet S, et al.
Publicado: (2011)

Absolute measurement of the tissue origins of cell-free DNA in the healthy state and following paracetamol overdose
por: Laurent, Danny, et al.
Publicado: (2020)

Assessing Paracetamol Overdose in Children: Acceptability and Potential Market for a Non-Invasive Testing Device
por: Freitas, Debora, et al.
Publicado: (2023)

PANSAID – PAracetamol and NSAID in combination: study protocol for a randomised trial
por: Thybo, Kasper Højgaard, et al.
Publicado: (2017)

Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir? – Authors' reply
por: Dear, James W.
Publicado: (2019)

Impact of different pack sizes of paracetamol in the United Kingdom and Ireland on intentional overdoses: a comparative study
por: Hawton, Keith, et al.
Publicado: (2011)

Student-selected component in the medical curriculum: investigations and psychiatric referral for paracetamol overdose in an accident and emergency department
por: Cowman, James G, et al.
Publicado: (2017)

Acetylcysteine for paracetamol: Will one size ever fit all?
por: Hoffman, Robert S.
Publicado: (2020)

Early PARacetamol (EPAR) trial: a study protocol for a randomised controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants
por: Schindler, Tim, et al.
Publicado: (2019)

Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial
por: Hay, Alastair D, et al.
Publicado: (2008)

Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial
Publicado: (2009)

The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx
por: Karlsson, Jan Olof G., et al.
Publicado: (2021)

Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn(2+) and Oxaliplatin-Associated Pt(2+)
por: Karlsson, Jan Olof G., et al.
Publicado: (2023)

Comment on “Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity” Antioxidants 2020, 9, 594
por: Stehr, Jan Eric, et al.
Publicado: (2020)

Development of a ‘patient information leaflet’ for use following assessment of patients with reported or suspected paracetamol overdose in the UK
por: Potter, Thomas, et al.
Publicado: (2014)

Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?
por: Kalsi, Sarbjeet S, et al.
Publicado: (2011)

Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies
por: Dear, James W, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hevci40rh6oedict5ip7lmf9aa